Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,489
Closed -$158K 163
2025
Q4
$158K Sell
1,489
-1,089
-42% -$110K 0.03% 197
2025
Q3
$242K Buy
+2,578
New +$240K 0.03% 165
2021
Q2
Sell
-7,516
Closed -$489K 163
2021
Q1
$489K Sell
7,516
-51,234
-87% -$3.15M 0.07% 138
2020
Q4
$3.23M Buy
+58,750
New +$3M 0.51% 52

Other funds holding ACA

Wexford Capital's ACA Position: Q1 2026 in Review

Wexford Capital sold out of Arcosa (ACA) in Q1 2026, closing a stake of 1,489 shares — an estimated $158K sold.

Wexford Capital first reported a position in ACA in Q4 2020 and held it in 4 quarters. The position peaked at $3.23M in Q4 2020. 372 funds tracked by Wall St. Rank hold ACA as of Q1 2026.

  • Wexford Capital reported no remaining Arcosa position as of Q1 2026 after selling out during the quarter.
  • Wexford Capital sold 1,489 Arcosa shares in Q1 2026, an estimated $158K.
  • Wexford Capital first reported a position in Arcosa in Q4 2020 and held it in 4 quarters.
  • Wexford Capital's Arcosa position peaked at $3.23M in Q4 2020.
  • 372 funds tracked by Wall St. Rank held Arcosa as of Q1 2026.

Based on Wexford Capital's 13F filing for Q1 2026, filed 15 May 2026.